Emma L. Welsh

Oct 24, 2024 | jamanetwork.com | Stephanie Jones |Julia Schiantarelli |Naomi R. Besson |Emma L. Welsh

Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma Maria E. Cabanillas, MD; Ramona Dadu, MD; Renata Ferrarotto, MD; Maria Gule-Monroe, MD; Suyu Liu, PhD; Bryan Fellman, MS; Michelle D. Williams, MD; Mark Zafereo, MD; Jennifer R. Wang, MD, PhD; Charles Lu, MD; Matthew Ning, MD; Brian A. McKinley, PhD; Scott E.